You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Core Informatics has satisfied Good Manufacturing Practice, Good Laboratory Practice, and Good Clinical Practice guidelines for the cloud version of its product.
2bPrecise is developing the needed ontology for its platform to enable clinicians to combine genomic and clinical data in their interactions with pediatric patients.
The company plans to use Thermo Fisher Scientific's newly launched PharmacoScan array-based platform for its testing.
BIG offers free use of the warehouse to internal researchers and is reaching out to local companies in the Buffalo area working in genomics and other areas.
DNAstack offers cloud-based access to bioinformatics solutions and mechanisms for sharing genomic data that leverage open APIs and resources.
The company has been working with NGS-based ctDNA testing for some time in research, but has now made its first move into the clinical sphere.
The app lets physicians use their mobile phones to access clinical trial matching capabilities from the broader GenoSpace portfolio.
Frameshift plans to commercialize two applications: one for data quality control and a second for identifying mutations in rare and Mendelian disorders.
Living DNA can break down the origins of a customer’s ancestry into 21 distinct regions within Britain alone, as well as across 80 different worldwide populations.
The platform features a more comprehensive list of pipelines, simplifies data movement and flow, and reduces analysis times.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.